Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Silicon Dioxide API
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Silicium Laboratories S.L. | San Antonio Technologies S.L. | Catholic University of Murcia (UCAM) | Zaidin Experimental Station, Spanish Council for Scientific Research (CSIC) Agency
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Silica is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 11, 2021
Lead Product(s) : Silicon Dioxide API
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Silicium Laboratories S.L. | San Antonio Technologies S.L. | Catholic University of Murcia (UCAM) | Zaidin Experimental Station, Spanish Council for Scientific Research (CSIC) Agency
Deal Size : Inapplicable
Deal Type : Inapplicable